Competition & Peer Data API & CSV Delivery

Medirom Healthcare Technologies Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Medirom Healthcare Technologies Inc (MRM) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q4 2024
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
22.56 %
Q4 2024
Net Margin
1.67 %
Q4 2024

Key Findings: Medirom Healthcare Technologies Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 57M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months).
  • Scale: Medirom Healthcare Technologies Inc ranks #31 of 41 companies by market capitalization in the Personal Services industry, holding 0.0% of industry market cap.
  • Peer revenue share: Medirom Healthcare Technologies Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

MRM Sales vs. its Competitors, Q4 2024

Medirom Healthcare Technologies Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/MRM/competitors
https://api.csimarket.com/api/v1/companies/MRM/relationships
https://api.csimarket.com/api/v1/companies/MRM/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Personal Services industry grew revenue 9.9% year over year, combined, vs 22.6% for Medirom Healthcare Technologies Inc. Medirom Healthcare Technologies Inc's share of combined industry revenue moved from 0.14% to 0.16%, a gain of 0.02 percentage points.

Medirom Healthcare Technologies Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Medirom Healthcare Technologies Inc - - - -
Similar-Size Competitors (9) 17% 86% 71% 14%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q4 2024

100%market share
  • Medirom Healthcare Technologies Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Medirom Healthcare Technologies Inc and its 0 tracked competitors.

See Medirom Healthcare Technologies Inc's full market share breakdown »

MRM Stock Performance relative to its Competitors

MRM Competitors (weighted) Percent change over the selected range

Medirom Healthcare Technologies Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
0%beat U.S.A. 500
Similar-Size
(0 of 6)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Medirom Healthcare Technologies Inc -44.50 % Underperformed
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (0) 40.4% 63.2%
Similar-Size Competitors (6) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Medirom Healthcare Technologies Inc's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

MRM Stock Performance relative to Similar-Size Competitors

MRM Similar-Size Competitors (equal-weighted, 9) Percent change over the selected range

Medirom Healthcare Technologies Inc's Comment on Competition and Industry Peers

The company utilizes the reputation of its CEO and its position as Japan's first relaxation company publicly listed in the United States to enhance its competitive advantage and negotiating power. It targets the acquisition of salon brands with a minimum of 10 stores and may consider acquiring major competitors under appropriate conditions. Since the fourth quarter of 2021, the company has adopted an operation outsourcing model, selling directly-owned salons to investors and managing their operations through service agreements. Under this model, the company earns contingent fees based on profits exceeding a predetermined investment yield. The approach is designed to maximize return on capital, accelerate the opening of new salons, and reinvest proceeds from salon sales.

Medirom Healthcare Technologies Inc's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
ZACC Named by the company 85% 2022 to 2026 3
K.K. Factory Japan Named by the company 85% 2022 to 2026 3
K.K. Bodywork Named by the company 85% 2022 to 2026 3
K.K. Factory Japan (Karada Factory) Named by the company 85% 2022 to 2026 3
K.K. Bodywork (Raffine) Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Medirom Healthcare Technologies Inc's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.